ACUTE MYELOGENOUS LEUKEMIA

This study tests a new immune cell treatment called AdaptNK for people with acute myeloid leukemia (AML) that has come back or not responded to standard therapy. The treatment uses specially grown natural killer cells from a donor to attack the leukemia, followed by a stem cell t…

This study tests whether a cord blood transplant (using stem cells from donated umbilical cord blood) can help children and young adults up to age 26 with blood cancers like leukemia or lymphoma. Participants receive the transplant as their first or second treatment. The main goa…

This study tests whether using stem cells from both a half-matched family donor and a cord blood donor can improve survival for people with high-risk blood cancers like leukemia or myelodysplastic syndromes. About 36 participants will receive the transplant and be followed for up…

This early-stage study tests a new drug (ICP-248) combined with a standard drug (azacitidine) in people with acute myeloid leukemia or myelodysplastic syndromes. The main goals are to check safety, find the best dose, and see if the combo helps control the cancer. About 266 adult…

This study looks at how the body processes venetoclax when the tablets are crushed and mixed into a liquid for children and young adults with blood cancers like leukemia or lymphoma. About 30 participants who already take venetoclax this way will have their blood levels measured.…

This study is gathering basic health and survival information from 2000 people who are getting a stem cell transplant for blood cancers or immune diseases. The goal is to build a database that doctors can use to improve care and answer future questions. No experimental treatments…

This study aims to gather information from cancer patients (breast, lung, ovarian, multiple myeloma, or AML) who use a remote symptom monitoring system during their routine treatment. Participants will complete weekly surveys about their symptoms for at least 12 weeks. The goal i…